Consistent with previous findings, we found that DGG-100629 induced JNK phosphorylation and that both transcriptional and pharmacological suppression of JNK reversed DGG-100629-induced DDIAS downregulation and restored cancer cell growth (Fig. 3). Here, MAPK8 is linked to cancer.